Muscle loss in cirrhosis: could a simple amino acid drink be the answer?
NCT ID NCT03208868
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether a leucine-enriched essential amino acid mixture can reverse muscle loss (sarcopenia) in people with liver cirrhosis. Researchers will give 32 participants either the active mixture or a placebo for 3 months, measuring muscle protein production and overall muscle mass. The goal is to find a safe, effective treatment to improve strength and reduce complications before and after liver transplant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cleveland Clinic Foundation
RECRUITINGCleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Decade-Long study aims to unlock liver disease risks in HIV-Hepatitis b patients
- Zambia study tracks hepatitis b outcomes in hundreds of patients
- New study tracks blood sugar in liver disease patients on common drug
- New drug aims to stop liver failure in NASH patients
- Can spleen surgery save kidneys in liver patients?
- Spleen surgery may change fat levels in liver patients โ study to watch